Authors:
NICHOLSON NS
TAITE BB
SZALONY JA
SALVERS AK
HAAS NF
PANZERKNODLE SK
ENGLEMAN VW
FEIGEN LP
PAGE JD
SEARLE GD
Citation: Ns. Nicholson et al., ORBOFIBAN IS A NEW ORALLY-ACTIVE ANTIPLATELET AGENT ACTING BY ANTAGONISM OF FIBRINOGEN BINDING, The FASEB journal, 12(5), 1998, pp. 4174-4174
Citation: Jd. Page et al., FLOW CYTOMETRIC MEASUREMENT OF THE EFFECTS OF SMALL-MOLECULE FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET EXPRESSION OF CD62P AND FACTOR-V BINDING, Thrombosis and haemostasis, 1997, pp. 2699-2699
Citation: Jd. Page et al., EFFECTS OF THE GP IIB IIIA ANTAGONIST SC-54701 ON FIBRIN GENERATION AND PLATELET-FIBRIN INTERACTIONS IN THROMBIN-INDUCED CLOT FORMATION ANDRETRACTION/, Thrombosis and haemostasis, 73(6), 1995, pp. 1315-1315
Authors:
ZABLOCKI JA
RICO JG
GARLAND RB
ROGERS TE
WILLIAMS K
SCHRETZMAN LA
RAO SA
BOVY PR
TJOENG FS
LINDMARK RJ
TOTH MV
ZUPEC ME
MCMACKINS DE
ADAMS SP
MIYANO M
MARKOS CS
MILTON MN
PAULSON S
HERIN M
JACQMIN P
NICHOLSON NS
PANZERKNODLE SG
HAAS NF
PAGE JD
SZALONY JA
TAITE BB
SALYERS AK
KING LW
CAMPION JG
FEIGEN LP
Citation: Ja. Zablocki et al., POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 38(13), 1995, pp. 2378-2394
Authors:
NICHOLSON NS
PANZERKNODLE SG
SALYERS AK
TAITE BB
SZALONY JA
HAAS NF
KING LW
ZABLOCKI JA
KELLER BT
BROSCHAT K
ENGLEMAN VW
HERIN M
JACQMIN P
FEIGEN LP
Citation: Ns. Nicholson et al., SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION, Circulation, 91(2), 1995, pp. 403-410
Authors:
SZALONY JA
HAAS NF
SALYERS AK
TAITE BB
NICHOLSON NS
MEHROTRA DV
FEIGEN LP
Citation: Ja. Szalony et al., EXTENDED INHIBITION OF PLATELET-AGGREGATION WITH THE ORALLY-ACTIVE PLATELET INHIBITOR SC-54684A, Circulation, 91(2), 1995, pp. 411-416
Authors:
SALYERS AK
SZALONY JA
TAITE BB
HAAS NF
MEHROTRA DV
FEIGEN LP
NICHOLSON NS
Citation: Ak. Salyers et al., A NEW METHOD FOR MEASUREMENT OF PLASMA-CONCENTRATION OF ORALLY-ACTIVEGLYCOPROTEIN IIB IIIA ANTAGONISTS/, Thrombosis research, 75(4), 1994, pp. 409-417
Authors:
NICHOLSON NS
HAAS NF
TAITE BB
PANZERKNODLE SG
KING LW
ABOOD NA
ZABLOCKI JA
RICO JG
SMITH JW
FEIGEN LP
Citation: Ns. Nicholson et al., DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE, Circulation, 90(4), 1994, pp. 181-181
Authors:
NICHOLSON NS
HAAS NF
TAITE BB
PANZERKNODLE SG
KING LW
ABOOD NA
ZABLOCKI JA
RICO JG
SMITH JW
FEIGEN LP
Citation: Ns. Nicholson et al., DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE, Circulation, 90(4), 1994, pp. 181-181